Coya Therapeutics, Inc.

COYA · Nasdaq · SIC 2834: Pharmaceutical Preparations
75
SEC Filings

Business Summary

PART I All references in this report to "Coya," the "Company," "we," "us," or "our" mean Coya Therapeutics, Inc. unless stated otherwise or the context otherwise indicates. Overview We are a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). Tregs are a subpopulation of T-lymphocytes consisting of CD4+CD25high hFOXP3+ cells that suppress inflammatory responses. Tregs were first discovered in 1995 by Dr. Shim...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCOYAdiscussed_in_filing Cybersecurity
topic_mentionCOYAdiscussed_in_filing Cybersecurity
topic_mentionCOYAdiscussed_in_filing Regulation
topic_mentionCOYAdiscussed_in_filing Healthcare & Bio
topic_mentionCOYAdiscussed_in_filing Regulation
topic_mentionCOYAdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001193125-26-107281EDGAR96K words
2025-03-182024-12-310000950170-25-040782EDGAR—
2024-03-192023-12-310000950170-24-033161EDGAR—
2023-03-292022-12-310000950170-23-010599EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001193125-25-276058EDGAR22K words
2025-08-122025-06-300000950170-25-106934EDGAR—
2025-05-132025-03-310000950170-25-069824EDGAR—
2024-11-062024-09-300000950170-24-121837EDGAR—
2024-08-122024-06-300000950170-24-095075EDGAR—
2024-05-092024-03-310000950170-24-057056EDGAR—
2023-11-082023-09-300000950170-23-060718EDGAR—
2023-08-082023-06-300000950170-23-039354EDGAR—
2023-05-102023-03-310000950170-23-020076EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-020001193125-26-139094EDGAR4K words
2026-03-160001193125-26-107276EDGAR—
2026-01-300001193125-26-030531EDGAR—
2026-01-200001193125-26-016017EDGAR—
2026-01-080001193125-26-007042EDGAR—
2025-12-170001193125-25-321737EDGAR—
2025-11-120001193125-25-276022EDGAR—
2025-10-270001193125-25-250709EDGAR—
2025-09-020001193125-25-193450EDGAR—
2025-08-120000950170-25-106932EDGAR—

75 total filings indexed. 52 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001835022
TickerCOYA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 1a28ae3baeda858676ba74a3f062c231aa02d448e85e1e11017bc1b41bff7a7c
parent: ce2c632048d3b854d47a6e35ca684a214a971622f07e23773373da300305adf4
content hash: 6dd22aa125be356cbf0b44d5739fa8667837bb3b602824880f88a9cdb412bb6d
signed: 2026-04-13T04:44:27.132Z
sources: 13 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf